Topics

Press Release: Affimed Announces Proposed Public Offering of Common Shares

16:42 EST 7 Nov 2019 | FinanzNachrichten

Heidelberg, Germany, November 7, 2019 -- Affimed N.V. ("Affimed" or the "Company") (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to giving patients back their innate ability...

Original Article: Press Release: Affimed Announces Proposed Public Offering of Common Shares

NEXT ARTICLE

More From BioPortfolio on "Press Release: Affimed Announces Proposed Public Offering of Common Shares"

Quick Search

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...